GlobalData on MSN1mon
FDA expands Pfizer’s RSV vaccine label to include all high-risk adultsThe US Food and Drug Administration (FDA) has expanded the indication for Pfizer’s respiratory syncytial virus (RSV) vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback